arrow
C

Colin Watts

University of Birmingham
H指数:49
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent genomic evolution in astrocytomas and oligodendrogliomas

星形胶质瘤和少突胶质瘤的基因组趋异进化

Nature
IF48.5
2026-10-140
OAAI
101 Independent replication and validation of nanopore-based long read sequencing and methylome classification for rapid brain tumour diagnosis

101 纳米孔长读长测序及甲基组分类在快速脑肿瘤诊断中的独立重复与验证

2026-08-270
OAAI
98 Barriers and opportunities in the integrated histopathological-molecular diagnosis of adult diffuse gliomas: a national survey of neuropathology units in UK&I

98 成人弥漫性胶质瘤整合组织病理学-分子诊断的障碍与机遇:英国及爱尔兰神经病理学单位的全国性调查

2026-08-270
OAAI
90 Developing Patient-Focused Outcomes for Routine Clinical Care in Glioma: A Synthesis of Qualitative Evidence from the COMBaT Study

90 胶质瘤常规临床护理中患者关注结局的制定:COMBaT研究的定性证据综合

2026-08-270
OAAI
Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial

胶质瘤手术中的癫痫预防(SPRING):一项多中心、非盲、随机试验

2026-01-012
PRE
Introduction of whole genome sequencing as NHS standard of care for glioma patients in two neurosurgical oncology centres: West Midlands

英国国家医疗服务体系(NHS)在两家神经外科肿瘤中心(西米德兰兹郡)中引入全基因组测序作为胶质瘤患者的标准治疗方案。

2025-11-110
OAAI
INDEPENDENT REPLICATION OF USE OF NANOPORE-BASED DIAGNOSTIC ASSAY FOR RAPID BRAIN TUMOUR DIAGNOSIS

纳米孔诊断检测在快速脑肿瘤诊断中的应用的独立重复验证

2025-11-010
OAAI
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

脑肿瘤液体活检方法中的前分析变量和检测物:RANO Group和Brain Liquid Biopsy Consortium的综述与建议

2025-08-010
PRE
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review

在偶发和未经治疗的颅内脑膜瘤的观察性研究中测量和报告的结果: 系统评价

2024-03-190
OAAI
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review

颅内脑膜瘤临床试验测量和报告的结果: 系统评价

2024-03-021
OAAI